Patent Application
App. No. 18/665,100
CRYSTALLINE DIPEPTIDES USEFUL IN THE SYNTHESIS OF ELAMIPRETIDE
Loading inventors, assignments & file history…
Abstract
Disclosed are crystalline forms of L-Lys (Boc)-Phe-NH 2 and Boc-D-Arg-DMT. The crystalline forms may be used in the synthesis of elamipretide.
Claims (6)
1 . A crystalline form of Compound (I),
wherein said crystalline form has characteristic peaks in its XRPD pattern at values of two theta as described in Table 1.
2 . A crystalline form of Compound (I),
wherein said crystalline form has characteristic peaks in its XRPD pattern at values of two theta as described in FIG. 1 .
3 - 8 . (canceled)
9 . A crystalline form or preparation process substantially as herein described.
Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Jul 12, 2024
From: DUNCAN, SCOTT M.; REDMON, MARTIN P.
To: STEALTH BIOTHERAPEUTICS CORP.
Reel/Frame 067974/0294 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Jul 12, 2024
From: STEALTH BIOTHERAPEUTICS CORP.
To: STEALTH BIOTHERAPEUTICS INC.
Reel/Frame 068310/0263 →